The Heliostat Exotic mission is now available to play in Destiny 2. Players can complete the mission to obtain the Wolfsbane Exotic Sword. The Sword comes with three further intrinsics and four perks ...
Qua Nilus II is one of several new Legendary weapons in The Edge of Fate in Destiny 2. This submachine gun doesn't have much going on with it, but it is a slower-fire rate weapon, making it one of the ...
The 9.1.5.3 Patch for Destiny 2 has arrived, bringing with it a small number of updates and fixes to improve game stability and ...
Bungie reveals the new Orders System for Destiny 2, which completely replaces bounties and seasonal challenges inside the ...
For PvP-oriented rolls of Aureus Neutralizer, there’s a handful of decent perks in each column, but in testing, we found the reliably consistent Lone Wolf and Opening Shot to be the most reliable.
It’s that time of year again in Destiny 2 , as the annual Festival of the Lost in-game event is once again underway. Running ...
Derek's love of games came at an early age when his parents first brought home the Nintendo Entertainment System. From then on, countless nights were spent hunting ducks, stomping turtles, exploring ...
Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Bungie’s decline in handling Destiny 2 is not a sudden occurrence, nor is it a surprise to anyone ...
FPS Boring, grindy and vindictive to veteran players: Destiny 2's Portal is a complete failure, and Bungie needs to take drastic action if it wants the game to survive FPS I have never known a Destiny ...
OpenAI's second-generation AI video model, Sora 2, is stirring up controversy, less than a week after the AI giant unveiled the highly anticipated tool and its corresponding app. The hubbub stems from ...
Journal Editorial Report: Obamacare subsidies take center stage in funding fight. Congressional Democrats have said the quiet part out loud: They want the federal government to keep cutting massive ...
Gilead Sciences and Arcus Biosciences’ anti-TIGIT antibody domvanalimab has been tied to median overall survival of close to 27 months, keeping alive one of the last remaining hopes for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback